Delphine Guillotin

Delphine Guillotin has extensive work experience in the field of scientific research. Delphine is currently working at Achilles Therapeutics plc as a Principal Scientist I, where they specialize in single-cell RNA and TCR sequencing. Their responsibilities include running experiments using B and T cells, analyzing data in R, and conducting experiments and analyses on clinical samples. Prior to this role, Delphine worked as a Senior Scientist at Achilles Therapeutics and held the position from March 2021 to February 2023.

Before joining Achilles Therapeutics, Delphine worked at UCL as a Senior Postdoctoral Research Associate from May 2017 to March 2021. During their time there, they were involved in various projects focused on identifying novel therapeutic strategies for pulmonary fibrosis. Their work included using techniques such as CRISPR, RNA sequencing, and cell culture.

Delphine's earlier work experience includes a role as a Postdoctoral Research Associate at The Institute of Cancer Research from May 2015 to April 2017. Delphine also worked as a PhD student at Barts Cancer Institute, Queen Mary University of London from September 2011 to May 2015.

Prior to their doctoral studies, Delphine worked as a Research Engineer at Inserm. Their responsibilities included miniaturizing and automating ChIP on chip on cells. Delphine held this role from October 2008 to August 2011.

Overall, Delphine Guillotin has a strong background in scientific research, with expertise in areas such as single-cell sequencing, pulmonary fibrosis, and molecular biology techniques.

Delphine Guillotin completed their Bachelor of Science (BSc) in Biochemistry and Molecular Biology at Université de Nantes, France from 2003 to 2006. Delphine then pursued a Master of Science (MSc) degree in Biology and Genomics at Université de Marseille, France from 2006 to 2008. Subsequently, they obtained their Doctor of Philosophy (PhD) in Molecular Biology from Queen Mary University of London from 2011 to 2015.